MANAGEMENT AND OUTCOME OF JAUNDICE SECONDARY TO MALIGNANCIES OF THE GALL BLADDER, BILIARY TREE AND PANCREAS: A SINGLE CENTRE EXPERIENCE

Adnan Salim, Sadia Jabbar, Farhan ul Amin, Kashif Malik

Abstract


Background: Obstructive jaundice due to malignancies of the biliary tree, gall bladder and pancreas account for a significant number of patients managed by tertiary centres. Management options are curative or palliative, depending on disease stage. This study was performed to see the effectiveness of treatment modalities for these patients and eventual outcome. Methods: This cross-sectional analytical study was conducted at the Department of Gastroenterology and Hepatology, Shaikh Zayed Hospital Lahore, from January 2015 to June 2016. All adult patients aged 18 and above of either sex presenting with obstructive jaundice secondary to malignant disease originating from the gallbladder, biliary-tree or pancreas were included in the study. The disease was staged after admission. The patients then underwent endoscopic, surgical or percutaneous drainage and were followed up for a period of one year. Results: two hundred & sixty-two patients presenting with jaundice due to malignancy arising from the biliary tree, gall bladder or pancreas were enrolled between January 2015 and June 2016, 141 (53.8%) males and 121 (46.2%) females. Eighty (30.5%) had cholangiocarcinoma, 70 (26.7%), had gall bladder tumours, 61 (23.3%) pancreatic cancer and 51(19.5%) had ampullary tumours. 31 (11.8%) patients had disease qualifying curative surgical resection. One hundred & eighty-five (70.6%) patients underwent palliative therapy in the form of percutaneous in 86 (32.9%) and endoscopic drainage in 126 (48.1%). Twenty-eight (10.7%) patients refused all treatment. Eighteen (6.9%) patients died before undergoing any therapeutic intervention. Thirty-three (12.6%) died during hospital stay. Survival at 3, 6 and 12 months was 49.2% (129 patients), 28.2% (74 patients) and 8.4% (22 patients), respectively. These 22 included all patients who had underwent curative resection. We attributed the largest number of deaths, 197 (75.2%) patients, to metastatic/advanced disease and associated complications. Conclusion: The results showed that patients with advanced disease who were only eligible for palliative therapy, at first presentation, constituted the majority of patients. These patients require skilled endoscopy and interventional radiology teams for successful biliary drainage.

Keywords: Gall bladder tumour; cholangiocarcinoma; ampullary tumour; pancreatic tumour; obstructive jaundice; ultrasound; CT scan; ERCP; percutaneous biliary drainage

Full Text:

PDF

References


Siddique K, Ali Q, Mirza S, Jamil A, Ehsan A, Latif S, et al. Evaluation of the aetiological spectrum of obstructive jaundice. J Ayub Med Coll Abbottabad 2008;20(4):62–6.

Aziz M, Ahmad N. Incidence of malignant Obstructive Jaundice-a study of hundred patients at Nishtar Hospital Multan. Ann King Edw Med Univ 2016;10(1):71–3.

Chen D, Liang LJ, Peng BG, Zhou Q, Li SQ, Tang D, et al. Effect of preoperative biliary drainage on liver function changes in patients with malignant obstructive jaundice in the low bile duct before and after pancreaticoduodenectomy. Ai Zheng 2008;27(1):78–82.

Lorenz JM. Management of Malignant Biliary Obstruction. Semin Intervent Radiol 2016;33(4):259–67.

Boulay BR, Birg A. Malignant biliary obstruction: From palliation to treatment. World J Gastrointest Oncol 2016;8(6):498–508.

Brown KT, Covey AM. Management of malignant biliary obstruction. Tech Vasc Interv Radiol 2008;11(1):43–50.

Gardner TB, Spangler CC, Byanova KL, Ripple GH, Rockacy MJ, Levenick JM, et al. Cost-effectiveness and clinical efficacy of biliary stents in patients undergoing neoadjuvant therapy for pancreatic adenocarcinoma in a randomized controlled trial. Gastrointest Endosc 2016;84(3):460–6.

Daróczi T, Bor R, Fábián A, Szabó E, Farkas K, Bálint A, et al. [Cost-effectiveness trial of self-expandable metal stents and plastic biliary stents in malignant biliary obstruction]. Orv Hetil 2016;157(7):268–74.

Martinez JM, Anene A, Bentley TG, Cangelosi MJ, Meckley LM, Ortendahl JD, et al. Cost Effectiveness of Metal Stents in Relieving Obstructive Jaundice in Patients with Pancreatic Cancer. J Gastrointest Cancer 2017;48(1):58–65.

Moy BT, Birk JW. An Update to Hepatobiliary Stents. J Clin Transl Hepatol 2015;3(1):67–77.

Dambrauskas Z, Paskauskas S, Lizadenis P, Uktveris R, Pranculis A, Kaupas RS, et al. Percutaneous transhepatic biliary stenting: the first experience and results of the Hospital of Kaunas University of Medicine. Medicina (Kaunas) 2008;44(12):969–76.

Bai AG, Zheng CS, Zhou GF, Liang HM, Feng GS. [Comparison of the therapeutic effects of PTBD and PTBS in treatment of malignant obstructive jaundice]. Zhonghua Zhong Liu Za Zhi 2010;32(6):456–8.

Lai EC, Lau SH, Lau WY. The current status of preoperative biliary drainage for patients who receive pancreaticoduodenectomy for periampullary carcinoma: a comprehensive review. Surgeon 2014;12(5):290–6.

Moole H, Bechtold M, Puli SR. Efficacy of preoperative biliary drainage in malignant obstructive jaundice: a meta-analysis and systematic review. World J Surg Oncol 2016;14(1):182.

Agbo SP, Oboirien M. Obstructive Jaundice: A Review of Clinical Experience in Resource Limited Setting. Merit Res J Med Med Sci 2017;5(7):349–53.

Gupta AK, Singh A, Goel S, Tank R. Profile and pattern of obstructive jaundice cases from a tertiary care teaching hospital of Uttar Pradesh. Int Surg J 2017;4(2):743–6.

van Delden OM, Lameris JS. Percutaneous drainage and stenting for palliation of malignant bile duct obstruction. Eur Radiol 2008;18(3):448–56.

Naitoh I, Ohara H, Nakazawa T, Ando T, Hayashi K, Okumura F, et al. Unilateral versus bilateral endoscopic metal stenting for malignant hilar biliary obstruction. J Gastroenterol Hepatol 2009;24(4):552–7.

Neal CP, Thomasset SC, Bools D, Sutton CD, Garcea G, Mann CD, et al. Combined percutaneous-endoscopic stenting of malignant biliary obstruction: results from 106 consecutive procedures and identification of factors associated with adverse outcome. Surg Endosc 2010;24(2):423–31.

Moses PL, Alnaamani KM, Barkun AN, Gordon SR, Mitty RD, Branch MS, et al. Randomized trial in malignant biliary obstruction: Plastic vs partially covered metal stents. World J Gastroenterol 2013;19(46):8638–46.

Guo YX, Li YH, Chen Y, Chen PY, Luo PF, Li Y, et al. Percutaneous transhepatic metal versus plastic biliary stent in treating malignant biliary obstruction: a multiple center investigation. Hepatobiliary Pancreat Dis Int 2003;2(4):594–7.


Refbacks

  • There are currently no refbacks.


Contact Number: +92-992-382571

email: [jamc] [@] [ayubmed.edu.pk]